Register entry

Smilax Laboratories Limited

Data as of · How to read this entry

Registered sites
2
Active NDC listings
4
Live patents
0
Countries
1
Base
India
Authorisation

Registered operations

Active ingredient (API) manufacture2
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Smilax Laboratories LimitedPlot No.12/A, Phase III, IDA, Jeedimetla, Hyderabad, Telangana 500055, India (IND)Active ingredient (API) manufacture3006251127650294866
Smilax Laboratories LimitedPlot No :70, Jawaharlal Nehru Pharma City, E-Bonangi Village, Parawada (M), Visakhapatnam, Andhra Pradesh 531019, India (IND)Active ingredient (API) manufacture3008772334677605764
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 bulk ingredient. By marketing category: BULK INGREDIENT 4.

Dosage formNDCs
powder4
RouteNDCs
Labeller name on the listingNDCs
smilax laboratories limited4
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
-Esomeprazole Magnesiumpowder71747-004BULK INGREDIENT
-GUAIFENESINpowder71747-003BULK INGREDIENT
-ITRACONAZOLEpowder71747-002BULK INGREDIENT
-OMEPRAZOLEpowder71747-001BULK INGREDIENT
Neighbours

Registered in the same town

12
Compare

Comparable companies in India

Enquiry

Common questions

Is Smilax Laboratories Limited FDA approved?
Smilax Laboratories Limited holds 2 FDA-registered establishments in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Smilax Laboratories Limited's drugs manufactured?
The FDA register lists Hyderabad; Visakhapatnam. Registered operations: active ingredient (API) manufacture.
What drugs does Smilax Laboratories Limited make?
4 products are listed under Smilax Laboratories Limited in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.